Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00639171 · ClinicalTrials.gov registry record
Evaluate the Use of the Magnetic Resonance Spectroscopy in Determining if the Breast Tumor is Benign or Malignant
A clinical trial, sponsored by State University of New York - Upstate Medical University.
- Completed
- Registry status
- 3
- Enrollment target
NCT00639171: Completed study, sponsored by State University of New York - Upstate Medical University.
NCT00639171 is a clinical trial that has completed, run by State University of New York - Upstate Medical University. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00639171 has completed, sponsored by State University of New York - Upstate Medical University.
- COMPLETED
- Registry status
- 3 participants
- Enrollment target
Study Summary
Magnetic Resonance Spectroscopy (MRS) is a novel imaging technique for noninvasive probing of biochemical properties of tissue. While MRS does not generate images of tumor per se it allows biochemical spectroscopic data to be obtained in vivo from user defined region-of-interest. In this manner, biochemical information elucidated by MRS can be interpreted in relation to detailed anatomy and images of metabolite distribution can be created. The aim of MRS is to identify presence and concentration of metabolites characteristic for normal and abnormal (tumor) cellular activities hence allow differential normal tissue from pathological tissue, as well as allow differentiating malignant from benign tumors.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2005-11 |
| Est. Completion | 2015-08 |
What the finished NCT00639171 record still lists
NCT00639171 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 3 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00639171 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00639171 about?
NCT00639171 is a clinical study titled "Evaluate the Use of the Magnetic Resonance Spectroscopy in Determining if the Breast Tumor is Benign or Malignant". Magnetic Resonance Spectroscopy (MRS) is a novel imaging technique for noninvasive probing of biochemical properties of tissue. While MRS does not generate images of tumor per se it allows biochemical spectroscopic data to be obtained in vivo from user defined region-of-interest. In this manner, bio...
What is the current status of trial NCT00639171?
This trial is currently completed. The enrollment target is 3 participants. The study started on 2005-11. Estimated completion is 2015-08.
Who is sponsoring clinical trial NCT00639171?
This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia